• LOGIN
  • SUBSCRIBE
  • FREE E-Newsletter/Product Bulletins

Cath Lab Digest

  • Follow us on
  • Home
  • About Us
    • Privacy Policy/Copyright
    • About VDM
  • Issues
    • Current Issue
    • Issue Archives
  • Editor's Update
  • Advertise
  • Reprints
  • Authors
    • Author Instructions
    • Submission Portal
  • Reviewers
  • Contact

Search

Volume 1 - Issue 2 - Nov/Dec 2004

Original Contribution »

Endovascular-First Strategy in Patients with Critical Limb Ischemia

By: Hassan Tehrani, MD, Chris Otero, MD, Mariano Arosemena, MD, Eduardo Perez, MD, Kenneth Zelnick, MD, Cesar Mendoza, MD, Jose Yrizarry, MD, Kevin Stadtlander, MD, Gary Rothenberg, MD, Michael Cohen, MD, Karin Zachow, MD, Alan Schob, MD

Introduction
Surgical bypass is considered the gold standard for the treatment of patients with chronic severe lower extremity ischemia.1,2 However, the 5-year limb salvage rates reported as high as 80% in single center/surgeon series have not been reproduced in multicenter studies or national registries.1,3,4 Often, these are extensive surgeries being performed in a mostly elderly patient population with multiple comorbidities. This has an impact on functional outcome. Only 45% of patients under going infrainguinal bypass reported feeling “back to normal” at

Read the full story »

Feature »

Initial Experience in the Treatment of Chronic Superficial Femoral Artery Occlusion with Fiberoptic Guidance Technology

By: Philip A. Morales, MD, Romas J. Kirvaitis, MD, Richard R. Heuser, MD

SUMMARY
Percutaneous treatment of chronic total occlusions may result in dissection or perforation. A fiberoptic guidance system that visualizes lesion characteristics and incorporates a radiofrequency energy source to aid in crossing total occlusions was used to cross five superficial femoral artery lesions, and there were no observed complications.

INTRODUCTION
Recent study of percutaneous intervention in chronic superficial femoral artery (SFA) occlusions indicates crossing the lesion is feasible in 68-100% of cases1-12 but that flow-limiting dissections and

Read the full story »

Feature »

Ipsilateral Lumbar Artery Coil Embolization Made Possible by the Technology of a Novel Guide Catheter: A Case Report

By: Gary M. Ansel, MD

The patient is a 83-year old male with an infrarenal abdominal aortic aneurysm (AAA) and right iliac aneurysm. Previously the patient underwent coil embolization of the proximal right hypogastric artery followed by stent grafting of the abdominal aortic aneurysm. The right limb of the stent graft ended in the proximal external iliac artery. At 1-month follow-up, a large type II endoleak via the inferior mesenteric artery was present. Repeat CT-scan completed at 3 months showed enlargement of the endoleak and a small amount of enlargement of the AAA. The patient underwent coil embolization of t

Read the full story »

Feature »

The CIS "Power-Pulse Spray" Technique

By: David E. Allie, MD

Introduction
Thrombus is now accepted as playing a key role in patients with acute myocardial infarction (AMI), unstable angina, acute coronary syndromes (ACS), deep venous thrombosis (DVT), pulmonary embolus (PE), and acute limb ischemia (ALI). Angioscopic evidence of thrombus was noted in a significant percentage of patients presenting with ACS and AMI by White et al.1 and large acute and subacute thrombus burdens are often associated with ALI, DVT, and PE. Thrombus formation is a complex process. It culminates in a final common pathway, with the thrombin cleavage of fibri

Read the full story »

Feature »

Commentary: Ipsilateral Lumbar Artery Coil Embolization Made Possible by the Technology of a New Novel Guide Catheter

By: J. Michael Bacharach, MD, MPH

The advent of endoluminal graft repair for abdominal aortic aneurysms has dramatically changed the therapeutic option for many patients. It is now well established that the devices can be safely inserted and short-term results have been excellent. Long-term outcome for many of these patients remains uncertain. The authors present a case report in which incomplete exclusion of the aneurysm with continued endoleak has resulted in aneurysm enlargement. As a result, the patient is not protected from continued expansion and the potential for eventual rupture. It is established in the literature tha

Read the full story »

Feature »

Ask the Expert: A Responsible Approach to Carotid Artery Stent (CAS) Training

By: Michael R. Jaff, DO, FACP, FACC

A national and international thought leader in the field of vascular medicine, Dr. Jaff recently served as the Medical Director of the Vascular Ultrasound Core Laboratory at the Cardiovascular Research Foundation in Morristown, New Jersey. He has lectured extensively throughout the world, and has authored numerous publications in the field. Dr. Jaff currently serves on the Editorial Board for Catheterization and Cardiovascular Intervention, Journal of Endovascular Therapy, Journal of Invasive Cardiology, and Angiology. He is currently President of the Society for Vascular Medic

Read the full story »

Interview »

Cyroplasty in the Treatment of Infrainguinal Arterial Disease: An Interview with James Joye, DO

Many physicians are exploring device use in the lower extremities, while techniques for successful and appropriate stenting are also being intensely discussed. Where does cryoplasty fit into the current picture?
Peripheral vascular disease, in general, is a relentless and proliferative process. With cryoplasty, whether it be in the fem-pop segment or below the knee, we are trying to achieve both better acute outcomes and long-term outcomes. What we're trying to accomplish is a minimization of the need for stent implants in the legs because they have their own set of problems and simu

Read the full story »

Interview »

Recognizing Expertise: Obtaining Certification by the American Board of Vascular Medicine

By: An interview with Michael R. Jaff, DO, Board of Directors, American Board of Vascular Medicine; Medical Director, Vascular Diagnostic Laboratory, Massachusetts General Hospital, Boston, Massachusetts

Why do you think this board is of value to the field of endovascular medicine?
Right now, there aren’t enough experts in vascular medicine to care for the masses of patients who have systemic atherosclerosis. So many different specialists are involved in the care of these patients that it’s hard to know who really has expertise in the overall management of patients with vascular disease. The concept behind the creation of the American Board of Vascular Medicine is to set a standard level so that people who have really dedicated themselves to the management of these patients and to

Read the full story »

Discussion Forum »

Discussion question: Will drug-eluting stens have a major impact in prevention of restenosis after non-coronary interventions? F

By: VDM editorial board members share their thoughts

Drug-eluting stents (DES) have revolutionized the treatment of obstructive coronary disease and expanding their applications to the periphery is inevitable. However, a better understanding of stent-associated restenosis in the periphery is needed.
1) The restenosis rate is very different in various vascular beds and clearly very high in infrainguinal vessels. The superficial femoral artery is probably the vascular bed that will be most in need of DES technology, given its long lesions and high restenosis rate.

2) The restenosis process in the periphery appears to continue beyond t

Read the full story »

Feature »

Combined Approach to Limb Salvage with Cryoplasty Therapy and Transmetatarsal Amputation in a Patient with Chronic Critical Limb

By: John E. Aruny, MD1, Peter Blume, DPM2, Bauer Sumpio, MD, PhD3, Benjamin Buren, DPM2

The patient is a 72-year-old woman who was transferred from a local area hospital for continued work up of PVD with ischemia of the third digit on the left foot. The patient had undergone attempted left lower extremity bypass. However, autogenous veins were found unsuitable to serve as conduit and the procedure was aborted. She was admitted to Yale-New Haven Hospital under the podiatric surgical service for a final attempt at limb salvage.

The patient has a significant past medical history: PVD, diabetes, coronary artery disease, hypertension, hypercholesterolemia, myocardial infarction, c

Read the full story »
  • « Previous
  •  | Page 1 of 2 | 
  • Next »

  • Advertise your Job Here
    For information on posting classified ads, please contact:
    Tara Fields, Classified Sales Manager
    (800) 237-7285, ext. 259

vdm Blogs

EVAR found superior to open AAA repair for long-term survival in Medicare patients: Another nail in open surgery’s coffin?

Frank J Criado MD FACS FSVM

Aneurysms and Cancer: Which comes first in the endovascular era?

Ross Milner MD FACS

What is the best therapy when we compare current data for revascularization of the SFA?

Lawrence A. Garcia MD

When a Patient Presents with an Ulcer, Take a Careful History

Richard R. Heuser MD FACC FACP FESC FSCAI

Long-term results with bare-metal LifeStent in the SFA: Is this bad news for DES technologies?

Frank J Criado MD FACS FSVM
more »

Vascular Newswire

  • PROMUS Element Stent Demonstrates Excellent Long-Term Safety and Effectiveness in PLATINUM Small Vessel Study
    Mon, 05/21/12 - 9:50am
  • Medtronic Nets New Indications for Resolute Integrity Drug-Eluting Stent in Europe
    Thu, 05/17/12 - 10:22am
  • Abbott's XIENCE PRIME and XIENCE V Drug Eluting Stents Receive Indication in Europe for Minimum Three-Month Duration of Dual Anti-Platelet Therapy
    Wed, 05/16/12 - 9:26am
  • Hospital Mortality Rates for Cardiovascular Revascularization Patients Varies Significantly by State
    Tue, 05/15/12 - 9:31am
more »

Clinical Events Calendar

  • International Vein Congress (IVC) 2012
    Thu, 05/31/2012 - Sun, 06/03/2012
    Miami Beach, FL, United States
  • New Cardiovascular Horizons (NCVH)
    Wed, 06/06/2012 - Sat, 06/09/2012
    New Orleans, LA, United States
  • Peripheral Vascular Surgery Society Annual Spring Meeting
    Thu, 06/07/2012 - Sat, 06/09/2012
    National Harbor, MD, United States
more »

Poll

The current focus to decrease the profile size of aortic stent-grafts: :
REVIEW OUR OTHER Cardiology BRANDS

Our other resources for healthcare professionals.

HMP Communications © 2012 HMP Communications

HMP Communications LLC (HMP) is the authoritative source for comprehensive information and education servicing healthcare professionals. HMP’s products include peer-reviewed and non-peer-reviewed medical journals, national tradeshows and conferences, online programs and customized clinical programs. HMP is a wholly owned subsidiary of HMP Communications Holdings LLC. ©2012 HMP Communications